ABSTRACT: Background In GALACTIC-HF (n=8,256), the cardiac myosin activator, omecamtiv mecarbil, significantly reduced the primary composite endpoint (PCE) of time-to-first heart failure event or c...
-
123456
ABSTRACT: Background In GALACTIC-HF (n=8,256), the cardiac myosin activator, omecamtiv mecarbil, significantly reduced the primary composite endpoint (PCE) of time-to-first heart failure event or c...